Virchow Foundation

für Globale Gesundheit

COUNCIL

Der Council bzw. Stiftungsbeirat der Virchow Foundation für Globale Gesundheit setzt sich aus Mitgliedern mit weitreichenden unterschiedlichen Expertisen und Kompetenzen und besonderem Fachwissen aus verschiedenen Bereichen (Wissenschaft, Zivilgesellschaft, Politik, internationale Organisationen, Privatwirtschaft) in möglichst weitgehender globaler Abdeckung zusammen. Im Rahmen seiner Arbeit kann der Council auch Ad-hoc- oder Langzeitausschüsse und Arbeitsgruppen für bestimmte Aktivitäten bilden.

Eine Kernaufgabe des Council betrifft die Vorschläge und die Wahl der Mitglieder des Virchow-Preis-Komitees.

Die Mitglieder des Council

  • beraten zur Ausrichtung der als gemeinnützig anerkannten Stiftung mit dem Ziel, den in der Satzung festgelegten Zweck und Auftrag zu verwirklichen;
  • geben Orientierung dazu, wie die Arbeit der Stiftung sowie der Virchow-Preis für Globale Gesundheit zu SDG 3 und den weiteren gesundheitsbezogenen Nachhaltigkeitszielen der Agenda 2030 der Vereinten Nationen beitragen können;
  • repräsentieren, fördern und unterstützen die Stiftung und ihre Ziele innerhalb der eigenen Netzwerke und bei relevanten Treffen und Veranstaltungen.

MITGLIEDER DES COUNCIL

HON. MICHEL SIDIBÉ
Co-Chair of the Council
Special Envoy for the Africa Medicine Agency (AMA)
African Union (AU)

MEET OUR COUNCIL MEMBERS

Michel Sidibé has championed a people-centred approach to health and development for over 40 years. He is a renowned tireless champion of African-owned solutions and has been an outspoken advocate for local pharmaceutical production of medicines and other essential health commodities. Honourable Sidibé significantly contributed to the efforts towards access to quality and safe medicines and vaccines and in fighting global inequities. In April 2021, Michel Sidibé was appointed African Union Special Envoy for the Africa Medicine Agency (AMA). Thanks to his high-level advocacy efforts, the treaty entered into force more promptly than expected on November 5, 2021From 2009-2019, he served as Executive Director of UNAIDS, holding the rank of Under-Secretary-General of the United Nations. Prior to joining UNAIDS, Honourable Michel Sidibé worked at UNICEF and for Terre des Hommes, where his passion for advancing global health and social justice began. Under his leadership at UNAIDS, more than 25 million people started life saving HIV treatment. A former Minister of Health and Social Affairs for Mali from 2019-2020, Sidibé has promoted health as an entry point for peace and security building. In 2021 he was appointed a board member of The Global Commission on Drug Policy. An economist by training, Michel Hamala Sidibé is the recipient of various African and global awards, including honorary doctorates from world’s leading universities. From 2009-2019, he served as Executive Director of UNAIDS, holding the rank of Under-Secretary-General of the United Nations. Prior to joining UNAIDS, Honourable Michel Sidibé worked at UNICEF and for Terre des Hommes, where his passion for advancing global health and social justice began. Under his leadership at UNAIDS, more than 25 million people started life saving HIV treatment. A former Minister of Health and Social Affairs for Mali from 2019-2020, Sidibé has promoted health as an entry point for peace and security building. In 2021 he was appointed a board member of The Global Commission on Drug Policy.

From your perspective, why is engagement and awareness raising for global health important?

Our human planet is facing an unprecedented global health crisis that has spread suffering and disrupted the lives of hundreds of millions of people. On every continent, countries face enormous pressure, as long-standing gaps in public health are exposed, and inequalities and injustices multiply. We have an overwhelming challenge ahead: reshaping our global health institutions to align with a radically different landscape.

We are in a defining moment in Africa!

COVID-19 has highlighted the need for stronger manufacturing capacity in Africa, paired with reliable procurement of locally manufactured products. From the onset of the pandemic, limited local supply of diagnostics, drugs, vaccines, and other products has caused delays in access across the continent. Africa has to be part of the on-going conversations on the need to building a more robust international health architecture that will protect future generations.

Africa, especially, has a difficult fight!

Long-term economic development has been constantly undermined by poor health systems and a high level of disease. Just 2% of the world’s doctors live in Sub-Saharan Africa. And many of the countries in the continent have just one doctor for up to 40,000 people, and five or fewer intensive care beds per 100,000 people. Health spending can reach up to 40% of household income in some African countries. Investments in health is key – there is need for building new solutions – from infrastructure to capacity development and building new health workforce to building digital health and telemedicine to new financial tools including health insurance to make this viable. Our main challenge is to generate and harness the much-needed political attention to health, as a priority for the continent’s long-term prosperity.

How are you committed to engaging in global health topics within your current professional role and activities?

The level of dependence on externally manufactured goods is problematic, as access to COVID-19 vaccines has reminded Africans. Local manufacturing of pharmaceuticals in the continent is, therefore, no longer an option. In fact, the continent produces only 3% of the medicines consumed by its people. Pharmaceutical supply chains have multiple intermediaries, contributing to the fact that drugs sold in Sub- Saharan Africa are often the most expensive in the world. In addition, Africa has the highest prevalence of substandard and falsified medicines (30%). These challenges have largely been attributed to weak or absent drug regulatory systems, with unclear policies and incomplete or inconsistent legal and regulatory frameworks. Acting at this level is therefore critically important. Africa´s leaders have made development of the pharmaceutical industry a key priority, as enshrined in the African Union´s Vision 2063, ´The Africa We Want´. Increasing the local manufacturing of vaccine, medicines and therapeutics requires partnerships between governments and companies for additional investments in science, technology, and innovation to improve health, spur economic growth, and reduce poverty across the continent. As African Union Special Envoy for the establishment of the African Medicine Agency, I am strongly committed to continue advocating for three transformative actions:

  1. Establish protective regulatory context for developing Hubs of Excellence for the production of vaccines, medicines and therapeutics
  2. Africanize Research and Development while galvanizing innovation and transfer of technology
  3. Mutualize competencies and think in terms of economies of scale.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

I am privileged to serve as Co-Chair of the Virchow Foundation for Global Health Council. The Foundation offers a unique platform to advocate for a transformative global agenda grounded in health equity and social justice, powerful scientific and medical tools, partnerships with governments, scientists, international organisations and civil society, and programmes that work to advance global health. I am convinced that the prestigious Virchow Prize for Global Health will contribute significantly to raising awareness and incentivising innovation to address critical public health challenges that Africa and the world are facing. I look forward to working with the other eminent members of the Council on this exciting endeavour.

PROF. DR. TILL BÄRNIGHAUSEN
Director, Heidelberg Institute of Global Health
Heidelberg University

PROF. DAME SALLY DAVIES
UK Special Envoy on AMR
Department of Health and Social Care

MEET OUR COUNCIL MEMBERS

Professor Dame Sally Davies is the Special Envoy on Antimicrobial Resistance for the United Kingdom. Prior to this role, Dame Sally was the Chief Medical Officer for England and Chief Medical Adviser to the UK government from March 2011 to September 2019, having held the post on an interim basis since June 2010. She shares her motivation for joining the Council and raising awareness for global health.

From your perspective, why is engagement and awareness raising for global health important?

We need the public to start driving action. On antimicrobial resistance (AMR), public engagement does not currently match the scale of the threat, and this will directly impact our ability to change behaviours and policies,. Everyone has a role – leadership can come from the top, as well as from grass-roots, so we need to work together.

How are you committed to engaging in global health topics within your current professional role and activities?

As UK Special Envoy on AMR, I engage bilaterally and multilaterally to raise awareness and drive action on AMR. In 2021, I advised the UK’s G7 Presidency to secure bold commitments on AMR, and I am now honoured to be a Member of  the UN Global Leaders Group on AMR to accelerate action across all sectors. I co-lead the UK’s Investor Action on AMR initiative to galvanise the voices and influence of investors to support antibiotic sustainability. In my role as Master of Trinity College, I founded and launched The Trinity Challenge, a global initiative to use data to better respond to global health emergencies.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

I hope to collaborate with other members to share expertise and best practice, and inspire collaboration across sectors and countries on global health. Our collective network will hopefully be able to find new ways and new platforms of engaging; I also hope to inspire young people to follow in the footsteps of Virchow Prize winners.

PROF. DR. CHRISTIAN DROSTEN
Director, Institute of Virology
Charité – Universitätsmedizin Berlin

PROF. DR. VICTOR J. DZAU
President
U.S. National Academy of Medicine (NAM)

MEET OUR COUNCIL MEMBERS

Victor J. Dzau, MD is the President of the National Academy of Medicine (NAM) in the United States. In addition, he serves as Vice Chair of the National Research Council. Dr Dzau is Chancellor Emeritus and James B. Duke Professor of Medicine at Duke University and the past President and CEO of the Duke University Health System. Previously, Dr Dzau was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital (BWH), as well as Chairman of the Department of Medicine and Director of the Falk Cardiovascular Research Center at Stanford University. As a member of the Virchow Foundation for Global Health Council, Dr Dzau is motivated to help honour special achievements in global health towards elevating visibility of the field.

From your perspective, why is engagement and awareness raising for global health important?

Advancing global health requires collective action. Health threats, such as infectious disease crises, do not respect national borders. There is a need to respond effectively to global health threats – both urgent crises and ongoing health challenges. In addition, there is a rising challenge of increasing rates of NCDs and endemic infections (e.g., TB, HIV/AIDS).

Achieving global health and well-being is an important part of the United Nations Sustainable Development Goals (UN SDGs). Individuals and governments have an important role to play. Stakeholders and decision-makers must act to promote the common good and renew their commitment to multilateralism and the multilateral system. Community engagement and trust is vital. Citizens can protect one another and demonstrate social and moral responsibility by acting in the best interests of all.

How are you committed to engaging in global health topics within your current professional role and activities?

From my childhood experience and life journey, beginning in post-war China, advancing global health and equity has always been a passion and commitment of mine.

Throughout my career, I have been active in numerous efforts to advance global health, including the founding of the Harvard BWH Division of Global Health Equity, the International Partnership in Innovation in Healthcare, the Duke Translational Medicine Institute, the Duke Global Health Institute, the Duke-National University of Singapore Graduate Medical School, and the Duke Institute for Health Innovation, and the founding of the Coalition for Epidemic Preparedness and Innovation.

In my current professional role, I engage in global health efforts in a number of ways, both in my capacity as President of the NAM and in my individual capacity. In both roles, I help shape and advise policies and initiatives that advance health globally.

At the National Academies, I helped design and launch the initiatives on Global Health Risk Framework; Global Health and Future Role of the US; Crossing the Global Quality Chasm and Human Genome Editing. I led the NAM’s response to COVID-19, which includes numerous committees, reports, consultations and communication on a range of issues including public health, vaccine allocation, health equity and mental health.

I have engaged with the global response to COVD-19 by providing leadership as a member of the Global Preparedness Monitoring Board, Co-chair of the G20 Scientific Expert Panel on Global Health Security, Advisor to the G20 High Level Independent Panel on Financing and a principal of the ACT-Accelerator which includes COVAX, the global collaboration for accelerating the development, manufacture and equitable distribution of COVID-19 vaccines.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

I look forward to serving with my esteemed colleagues on the Virchow Foundation for Global Health Council to contribute to the improvement of health worldwide. The Council offers an important platform to work across sectors and regions to elevate global health and raise the visibility of the field. Furthermore, the Council oversees the Virchow Prize for Global Health which offers an important opportunity to recognize the special merits and achievements in the field of global health. The Prize is important to the field, since there is arguably no global health award or prize on the scale of other scientific and medical prizes, such as the Nobel Prize or the Lasker Awards. As a member of the Council, I look forward to championing this important effort.

DR. RANA A. HAJJEH
Director, Program Management (DPM)
World Health Organization (WHO), Egypt

MEET OUR COUNCIL MEMBERS

Dr Hajjeh is a senior public health leader with 25 years of experience in global health, health policy and diplomacy, and health management, especially in the Middle East Region. Since 2019, Dr Hajjeh serves as the Director of Programme Management at the World Health Organization Eastern Mediterranean Regional Office (WHO/EMRO). Prior to this role, she held the position of the Director of the Department of Communicable Diseases Prevention and Control. Prior to joining WHO/EMRO in 2016, Dr Hajjeh worked with the United States Centers for Disease Prevention and Control for 23 years. Dr Hajjeh is motivated to join the Council to bring more visibility to global health priorities.

From your perspective, why is engagement and awareness raising for global health important?

It is critical to get more commitment from all key stakeholders including governments, partners, people and communities. With Covid-19 in particular, but for many other important cross cutting public health issues, such as infectious diseases and environmental health, it has become very clear that “no one is safe until everyone is safe”. Better awareness of global health issues will be critical to ensure more support at all levels for the important issues that affect us all, more resources and capacity building, and more accountability. 

How are you committed to engaging in global health topics within your current professional role and activities?

As part of my role as senior WHO official, and as overseeing all technical health issues in the region, I am responsible for ensuring we focus on implementing the many global health strategies, closely monitoring and seeing results at country level. I am also engaged in the development of many of these policies, supporting countries, and advocating for the importance of stronger global health systems and platforms.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

In my role with the foundation, I would like to bring more awareness of global health priorities from the WHO overall and especially regional perspectives, and a better sense of real challenges on the ground, as well as what is currently done and being achieved, so we don’t duplicate efforts. I think the Virchow prize will bring important visibility to global health and hopefully motivate further achievements in this area as well.

DR. CHIKWE IHEKWEAZU
Assistant Director-General
World Health Organization (WHO), Switzerland

PROF. DR. ILONA KICKBUSCH
Founding Director, Global Health Centre
Graduate Inst. of Intl and Development Studies Geneva

PROF. DR. HEIDI LARSON
Founding Director, The Vaccine Confidence Project
London School of Hygiene & Tropical Medicine

PROF. DR. JOANNE LIU
School of Population and Global Health (SPGH)
Faculty of Medicine and Health Sciences, McGill University

PROF. DR. ELIZABETH MACINTYRE
Board Member, Biomedical Alliance in Europe
President, European Hematology Association (EHA)

BENOÎT MIRIBEL
Secretary General
One Sustainable Health Forum, France

DR. MATSHIDISO MOETI
WHO Regional Director for Africa
World Health Organization (WHO), DRC

DR. ANDERS NORDSTRÖM
Ambassador for Global Health
Ministry of Foreign Affairs, Sweden

PROF. DR. TOLULLAH ONI
Director, Global Diet and Physical Activity Group
University of Cambridge

PROF. DR. OLE PETTER OTTERSEN
President
Karolinska Institutet

PROF. DR. NICOLE REDVERS
Associate Professor, University of Ontario
Western Research Chair & Director, Indigenous Planetary Health

PROF. DR. JÖRG ROCHOLL

Präsident
ESMT European School of Management and Technology

PROF. DR. JOHN-ARNE RØTTINGEN

Ambassador for Global Health
Ministry of Foreign Affairs, Norway

MEET OUR COUNCIL MEMBERS

Meet Dr. John-Arne Røttingen, Ambassador for Global Health of NorwayDr. John-Arne Røttingen, MD, PhD, MSc, MPA, is currently Ambassador for Global Health at the Ministry of Foreign Affairs of Norway. He received his MD and PhD from the University of Oslo, an MSc from Oxford University and an MPA from Harvard, where he is adjunct professor at the Department of Global Health and Population at Harvard T.H. Chan School of Public Health. In addition, he is Adjunct Scientific Director at the Norwegian Institute of Public Health and Visiting Fellow of Practice at Blavatnik School of Government, Oxford University, and was the founding interim Chief Executive Officer of CEPI (Coalition for Epidemic Preparedness Innovations). Prior to his role in the Ministry of Foreign Affairs, he was the Chief Executive of the Research Council of Norway; Executive Director of Infection Control and Environmental Health at the Norwegian Institute of Public Health; Professor of Health Policy at the Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo. He has been the founding Chief Executive of the Norwegian Knowledge Centre for Health Services; Oxford Scholar at Wadham College; Fulbright Fellow at Harvard Kennedy School; Chair of the Board of the Alliance for Health Policy and Systems Research; and Chair of the Consultative Expert Working Group on Research and Development: Financing and Coordination (CEWG), WHO (World Health Organization). As a member of the Virchow Foundation Council, Ambassador Røttingen is motivated to help contribute to a broader visibility and understanding of global health amongst the public.  

From your perspective, why is engagement and awareness raising for global health important?

All humans deserve a long and healthy life. This is a human right, and it is also a prerequisite for individuals to being able to work and contribute to society. Healthy lives are therefore both a goal and a means to sustainable development.  

How are you committed to engaging in global health topics within your current professional role and activities?

As an ambassador for Global Health of Norway my role is to support the Norwegian government in continuing strong contributions to Global Health. We are aiming to achieve this with our investments in multilateral health efforts, as well as with contributions to our collective international system, norms, and regulations so they are better fit for purpose. 

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

The Virchow Prize for Global Health provides a wonderful opportunity for rewarding important innovations and contributions to Global Health. Honouring such efforts will also contribute to a broader visibility and understanding in society and public of the immense importance of working to improve Global Health for all.

PROF. DR. LUCIANO SASO
Vice Director
Sapienza Università di Roma

DR. BERNHARD SCHWARTLÄNDER
Botschafter für Globale Gesundheit
Botschaft der Bundesrepublik Deutschland, Peking

PROF. DR. AMIRHOSSEIN TAKIAN
Vice Dean, School of Public Health
Tehran University of Medical Sciences

MEET OUR COUNCIL MEMBERS

Meet Dr. John-Arne Røttingen, Ambassador for Global Health of Norway

Professor Amirhossein Takian graduated from Shahed Medical University and received his PhD in Health Policy & Health Services Research from the London School of Hygiene & Tropical Medicine (LSHTM) in 2009. Amirhossein Takian then completed his postdoctoral fellowship in Health Sector Reform Evaluation at the University College London. Since August 2020, he holds a professorship in Health Policy & Global Health at the School of Public Health of the Tehran University of Medical Sciences.

Currently, Professor Dr. Amirhossein Takian is Head of the Department of Global Health & Public Policy, as well as Vice Dean of the School of Public Health of the Tehran University of Medical Sciences. By joining the Council of the Virchow Foundation for Global Health, he hopes to continuously spur recognition and engagement for global health.

From your perspective, why is engagement and awareness raising for global health important?

People empowerment is the key to improving health and well-being of global citizens. With the increasing burden of noncommunicable diseases (NCDs) and other chronic conditions, and the “global village” we all live in, people need to take social responsibility to stay healthy and contribute to their societies.

How are you committed to engaging in global health topics within your current professional role and activities?

I have three hats in this regard. As an academic, I have established the only department of global health in the pioneer university of my country. In this role, I am engaging with global scholars to improve knowledge, train global health professionals, and answer key global health questions in Iran and our region. As a policy maker, I have been trying my best to use good evidence to inform reliable and feasible policies, for sustainable health development. As an advocate, my passion and goal is creating a reasonable environment for good governance in global health, through addressing conflict of interests, increasing public awareness as well as enhancing transparency and responsiveness.

How do you hope to achieve greater awareness and engagement for global health in your new role at the Virchow Foundation for Global Health? How can the Virchow Prize for Global Health help to increase awareness?

Through identification of key global health challenges, recognition of main contributions to address them, engagement with an inclusive and comprehensive group of scholars from various settings (low-, middle-, and high-income countries), and partial allocation of the Virchow Prize for Global Health to practice and investment in global health. The Prize can serve as a product [and have an] impact [in increasing engagement], [more so] than a [single] person. [Laureates] need to be determined with careful consideration and good consensus from key Members of the Virchow Prize Committee.

PROF. DR. LOTHAR H. WIELER
Präsident
Robert Koch-Institut

GÄSTE DES COUNCIL

PROF. DR. EUGENIO GAUDIO
International President | World Health Summit 2022
President | Rome Sapienza Foundation

Hinweis: Die Mitglieder des Councils der Virchow Foundation für Globale Gesundheit werden sukzessive vorgestellt – bitte klicken Sie auf den “Zur Person”-Button – zudem in unserem Newsletter sowie im News-Bereich dieser Website, außerdem in den sozialen Medien. Schauen Sie also bitte von Zeit zu Zeit wieder auf unserer Website vorbei.